nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCC2—Tamoxifen—pancreatic cancer	0.115	0.161	CbGbCtD
Spironolactone—ABCC2—Irinotecan—pancreatic cancer	0.0884	0.124	CbGbCtD
Spironolactone—ABCC2—Docetaxel—pancreatic cancer	0.0648	0.0909	CbGbCtD
Spironolactone—ABCC2—Sunitinib—pancreatic cancer	0.0645	0.0904	CbGbCtD
Spironolactone—CYP2C8—Tamoxifen—pancreatic cancer	0.0555	0.0778	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—pancreatic cancer	0.0483	0.0677	CbGbCtD
Spironolactone—CYP2C8—Erlotinib—pancreatic cancer	0.0472	0.0661	CbGbCtD
Spironolactone—CYP2C8—Fluorouracil—pancreatic cancer	0.0409	0.0573	CbGbCtD
Spironolactone—ABCB1—Tamoxifen—pancreatic cancer	0.0375	0.0526	CbGbCtD
Spironolactone—ABCB1—Gemcitabine—pancreatic cancer	0.0323	0.0453	CbGbCtD
Spironolactone—ABCB1—Erlotinib—pancreatic cancer	0.0319	0.0448	CbGbCtD
Spironolactone—ABCB1—Irinotecan—pancreatic cancer	0.0288	0.0404	CbGbCtD
Spironolactone—ABCB1—Docetaxel—pancreatic cancer	0.0211	0.0296	CbGbCtD
Spironolactone—ABCB1—Sunitinib—pancreatic cancer	0.021	0.0295	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—pancreatic cancer	0.0157	0.0221	CbGbCtD
Spironolactone—ABCC2—bile duct—pancreatic cancer	0.00693	0.407	CbGeAlD
Spironolactone—ABCC2—bile—pancreatic cancer	0.00533	0.313	CbGeAlD
Spironolactone—Gastrointestinal symptom NOS—Fluorouracil—pancreatic cancer	0.00253	0.0148	CcSEcCtD
Spironolactone—Breast pain—Tamoxifen—pancreatic cancer	0.00253	0.0147	CcSEcCtD
Spironolactone—Amenorrhoea—Tamoxifen—pancreatic cancer	0.00251	0.0146	CcSEcCtD
Spironolactone—Rash erythematous—Sunitinib—pancreatic cancer	0.00246	0.0144	CcSEcCtD
Spironolactone—Vasculitis—Tamoxifen—pancreatic cancer	0.00226	0.0132	CcSEcCtD
Spironolactone—Cramps of lower extremities—Tamoxifen—pancreatic cancer	0.00202	0.0118	CcSEcCtD
Spironolactone—Menstruation irregular—Docetaxel—pancreatic cancer	0.00194	0.0113	CcSEcCtD
Spironolactone—Hyperkalaemia—Sunitinib—pancreatic cancer	0.00185	0.0108	CcSEcCtD
Spironolactone—Renal failure acute—Erlotinib—pancreatic cancer	0.00171	0.00999	CcSEcCtD
Spironolactone—Ulcer—Irinotecan—pancreatic cancer	0.00164	0.00958	CcSEcCtD
Spironolactone—Ulcer—Gemcitabine—pancreatic cancer	0.0016	0.00933	CcSEcCtD
Spironolactone—Ulcer—Fluorouracil—pancreatic cancer	0.00157	0.00917	CcSEcCtD
Spironolactone—Vasculitis—Gemcitabine—pancreatic cancer	0.00155	0.00904	CcSEcCtD
Spironolactone—Renal failure acute—Sunitinib—pancreatic cancer	0.00148	0.00865	CcSEcCtD
Spironolactone—Cramp muscle—Tamoxifen—pancreatic cancer	0.00144	0.00839	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.00143	0.00831	CcSEcCtD
Spironolactone—Rash erythematous—Docetaxel—pancreatic cancer	0.0014	0.00818	CcSEcCtD
Spironolactone—Gastritis—Erlotinib—pancreatic cancer	0.0014	0.00816	CcSEcCtD
Spironolactone—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.00127	0.00742	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.00123	0.00719	CcSEcCtD
Spironolactone—Amenorrhoea—Docetaxel—pancreatic cancer	0.00122	0.00713	CcSEcCtD
Spironolactone—Renal failure acute—Irinotecan—pancreatic cancer	0.00122	0.00712	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00122	0.00712	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00121	0.00705	CcSEcCtD
Spironolactone—Renal failure—Erlotinib—pancreatic cancer	0.0012	0.00699	CcSEcCtD
Spironolactone—Lethargy—Fluorouracil—pancreatic cancer	0.0011	0.00643	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00105	0.0061	CcSEcCtD
Spironolactone—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00105	0.0061	CcSEcCtD
Spironolactone—Renal failure—Sunitinib—pancreatic cancer	0.00104	0.00605	CcSEcCtD
Spironolactone—Erythema multiforme—Erlotinib—pancreatic cancer	0.00104	0.00603	CcSEcCtD
Spironolactone—Ataxia—Fluorouracil—pancreatic cancer	0.00102	0.00592	CcSEcCtD
Spironolactone—Cramp muscle—Irinotecan—pancreatic cancer	0.00102	0.00592	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00099	0.00577	CcSEcCtD
Spironolactone—Alopecia—Tamoxifen—pancreatic cancer	0.000978	0.0057	CcSEcCtD
Spironolactone—Alopecia—Erlotinib—pancreatic cancer	0.000968	0.00564	CcSEcCtD
Spironolactone—Rash erythematous—Epirubicin—pancreatic cancer	0.000947	0.00552	CcSEcCtD
Spironolactone—Muscle spasms—Tamoxifen—pancreatic cancer	0.000926	0.0054	CcSEcCtD
Spironolactone—Eosinophilia—Fluorouracil—pancreatic cancer	0.000925	0.00539	CcSEcCtD
Spironolactone—Erythema multiforme—Sunitinib—pancreatic cancer	0.000896	0.00522	CcSEcCtD
Spironolactone—Rash erythematous—Doxorubicin—pancreatic cancer	0.000876	0.0051	CcSEcCtD
Spironolactone—Leukopenia—Tamoxifen—pancreatic cancer	0.000862	0.00503	CcSEcCtD
Spironolactone—Renal failure—Irinotecan—pancreatic cancer	0.000855	0.00498	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00084	0.00489	CcSEcCtD
Spironolactone—Alopecia—Sunitinib—pancreatic cancer	0.000838	0.00488	CcSEcCtD
Spironolactone—Renal failure—Gemcitabine—pancreatic cancer	0.000833	0.00485	CcSEcCtD
Spironolactone—Breast pain—Epirubicin—pancreatic cancer	0.000831	0.00484	CcSEcCtD
Spironolactone—Amenorrhoea—Epirubicin—pancreatic cancer	0.000825	0.00481	CcSEcCtD
Spironolactone—Discomfort—Tamoxifen—pancreatic cancer	0.00081	0.00472	CcSEcCtD
Spironolactone—Lethargy—Docetaxel—pancreatic cancer	0.000796	0.00464	CcSEcCtD
Spironolactone—Muscle spasms—Sunitinib—pancreatic cancer	0.000793	0.00462	CcSEcCtD
Spironolactone—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000791	0.00461	CcSEcCtD
Spironolactone—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000777	0.00453	CcSEcCtD
Spironolactone—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00077	0.00449	CcSEcCtD
Spironolactone—Breast pain—Doxorubicin—pancreatic cancer	0.000769	0.00448	CcSEcCtD
Spironolactone—Ulcer—Epirubicin—pancreatic cancer	0.000766	0.00447	CcSEcCtD
Spironolactone—Amenorrhoea—Doxorubicin—pancreatic cancer	0.000763	0.00445	CcSEcCtD
Spironolactone—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000762	0.00444	CcSEcCtD
Spironolactone—Leukopenia—Sunitinib—pancreatic cancer	0.000739	0.0043	CcSEcCtD
Spironolactone—Ataxia—Docetaxel—pancreatic cancer	0.000734	0.00428	CcSEcCtD
Spironolactone—NR3C2—digestive system—pancreatic cancer	0.000729	0.0428	CbGeAlD
Spironolactone—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000719	0.00419	CcSEcCtD
Spironolactone—Hyperkalaemia—Epirubicin—pancreatic cancer	0.000712	0.00415	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—pancreatic cancer	0.000709	0.00413	CcSEcCtD
Spironolactone—Cramp muscle—Docetaxel—pancreatic cancer	0.000703	0.00409	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000703	0.00409	CcSEcCtD
Spironolactone—Alopecia—Irinotecan—pancreatic cancer	0.00069	0.00402	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000679	0.00396	CcSEcCtD
Spironolactone—Alopecia—Gemcitabine—pancreatic cancer	0.000672	0.00392	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000672	0.00391	CcSEcCtD
Spironolactone—Cramps of lower extremities—Epirubicin—pancreatic cancer	0.000666	0.00388	CcSEcCtD
Spironolactone—Alopecia—Fluorouracil—pancreatic cancer	0.000661	0.00385	CcSEcCtD
Spironolactone—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000659	0.00384	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—pancreatic cancer	0.000659	0.00384	CcSEcCtD
Spironolactone—Muscle spasms—Irinotecan—pancreatic cancer	0.000653	0.00381	CcSEcCtD
Spironolactone—NR3C1—islet of Langerhans—pancreatic cancer	0.000651	0.0382	CbGeAlD
Spironolactone—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000631	0.00368	CcSEcCtD
Spironolactone—SLCO1A2—digestive system—pancreatic cancer	0.000625	0.0367	CbGeAlD
Spironolactone—Urticaria—Tamoxifen—pancreatic cancer	0.000625	0.00364	CcSEcCtD
Spironolactone—Cramps of lower extremities—Doxorubicin—pancreatic cancer	0.000616	0.00359	CcSEcCtD
Spironolactone—Body temperature increased—Erlotinib—pancreatic cancer	0.000615	0.00358	CcSEcCtD
Spironolactone—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000614	0.00358	CcSEcCtD
Spironolactone—Malaise—Irinotecan—pancreatic cancer	0.000613	0.00357	CcSEcCtD
Spironolactone—Leukopenia—Irinotecan—pancreatic cancer	0.000608	0.00355	CcSEcCtD
Spironolactone—Malaise—Gemcitabine—pancreatic cancer	0.000597	0.00348	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000596	0.00347	CcSEcCtD
Spironolactone—Leukopenia—Gemcitabine—pancreatic cancer	0.000593	0.00345	CcSEcCtD
Spironolactone—Renal failure—Docetaxel—pancreatic cancer	0.000591	0.00344	CcSEcCtD
Spironolactone—Leukopenia—Fluorouracil—pancreatic cancer	0.000583	0.0034	CcSEcCtD
Spironolactone—ABCC2—digestive system—pancreatic cancer	0.000582	0.0342	CbGeAlD
Spironolactone—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000581	0.00339	CcSEcCtD
Spironolactone—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000579	0.00338	CcSEcCtD
Spironolactone—Discomfort—Irinotecan—pancreatic cancer	0.000572	0.00333	CcSEcCtD
Spironolactone—Renal failure acute—Epirubicin—pancreatic cancer	0.00057	0.00332	CcSEcCtD
Spironolactone—Agranulocytosis—Docetaxel—pancreatic cancer	0.000561	0.00327	CcSEcCtD
Spironolactone—Confusional state—Irinotecan—pancreatic cancer	0.000559	0.00326	CcSEcCtD
Spironolactone—Discomfort—Gemcitabine—pancreatic cancer	0.000557	0.00325	CcSEcCtD
Spironolactone—Pruritus—Tamoxifen—pancreatic cancer	0.000556	0.00324	CcSEcCtD
Spironolactone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000555	0.00323	CcSEcCtD
Spironolactone—Pruritus—Erlotinib—pancreatic cancer	0.00055	0.00321	CcSEcCtD
Spironolactone—Discomfort—Fluorouracil—pancreatic cancer	0.000548	0.00319	CcSEcCtD
Spironolactone—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000543	0.00317	CcSEcCtD
Spironolactone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00054	0.00315	CcSEcCtD
Spironolactone—AR—digestive system—pancreatic cancer	0.00054	0.0317	CbGeAlD
Spironolactone—Diarrhoea—Tamoxifen—pancreatic cancer	0.000538	0.00314	CcSEcCtD
Spironolactone—Lethargy—Epirubicin—pancreatic cancer	0.000537	0.00313	CcSEcCtD
Spironolactone—Confusional state—Fluorouracil—pancreatic cancer	0.000536	0.00312	CcSEcCtD
Spironolactone—Body temperature increased—Sunitinib—pancreatic cancer	0.000532	0.0031	CcSEcCtD
Spironolactone—Diarrhoea—Erlotinib—pancreatic cancer	0.000532	0.0031	CcSEcCtD
Spironolactone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000531	0.0031	CcSEcCtD
Spironolactone—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000529	0.00308	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—pancreatic cancer	0.000527	0.00307	CcSEcCtD
Spironolactone—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00052	0.00303	CcSEcCtD
Spironolactone—Dizziness—Tamoxifen—pancreatic cancer	0.00052	0.00303	CcSEcCtD
Spironolactone—Dizziness—Erlotinib—pancreatic cancer	0.000514	0.003	CcSEcCtD
Spironolactone—Erythema multiforme—Docetaxel—pancreatic cancer	0.00051	0.00297	CcSEcCtD
Spironolactone—Vomiting—Tamoxifen—pancreatic cancer	0.0005	0.00291	CcSEcCtD
Spironolactone—Lethargy—Doxorubicin—pancreatic cancer	0.000497	0.0029	CcSEcCtD
Spironolactone—Hypersensitivity—Sunitinib—pancreatic cancer	0.000496	0.00289	CcSEcCtD
Spironolactone—Rash—Tamoxifen—pancreatic cancer	0.000496	0.00289	CcSEcCtD
Spironolactone—Dermatitis—Tamoxifen—pancreatic cancer	0.000495	0.00289	CcSEcCtD
Spironolactone—Ataxia—Epirubicin—pancreatic cancer	0.000495	0.00288	CcSEcCtD
Spironolactone—Vomiting—Erlotinib—pancreatic cancer	0.000495	0.00288	CcSEcCtD
Spironolactone—Somnolence—Irinotecan—pancreatic cancer	0.000493	0.00287	CcSEcCtD
Spironolactone—Headache—Tamoxifen—pancreatic cancer	0.000493	0.00287	CcSEcCtD
Spironolactone—Rash—Erlotinib—pancreatic cancer	0.00049	0.00286	CcSEcCtD
Spironolactone—Dermatitis—Erlotinib—pancreatic cancer	0.00049	0.00286	CcSEcCtD
Spironolactone—Headache—Erlotinib—pancreatic cancer	0.000487	0.00284	CcSEcCtD
Spironolactone—Somnolence—Gemcitabine—pancreatic cancer	0.00048	0.0028	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000479	0.00279	CcSEcCtD
Spironolactone—Alopecia—Docetaxel—pancreatic cancer	0.000477	0.00278	CcSEcCtD
Spironolactone—Pruritus—Sunitinib—pancreatic cancer	0.000476	0.00278	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000474	0.00276	CcSEcCtD
Spironolactone—Somnolence—Fluorouracil—pancreatic cancer	0.000472	0.00275	CcSEcCtD
Spironolactone—Nausea—Tamoxifen—pancreatic cancer	0.000467	0.00272	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000466	0.00272	CcSEcCtD
Spironolactone—Gastritis—Epirubicin—pancreatic cancer	0.000466	0.00271	CcSEcCtD
Spironolactone—Nausea—Erlotinib—pancreatic cancer	0.000462	0.00269	CcSEcCtD
Spironolactone—Diarrhoea—Sunitinib—pancreatic cancer	0.000461	0.00269	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000459	0.00267	CcSEcCtD
Spironolactone—Ataxia—Doxorubicin—pancreatic cancer	0.000458	0.00267	CcSEcCtD
Spironolactone—NR3C1—pancreas—pancreatic cancer	0.000458	0.0269	CbGeAlD
Spironolactone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000457	0.00266	CcSEcCtD
Spironolactone—Muscle spasms—Docetaxel—pancreatic cancer	0.000452	0.00263	CcSEcCtD
Spironolactone—Eosinophilia—Epirubicin—pancreatic cancer	0.00045	0.00262	CcSEcCtD
Spironolactone—Dizziness—Sunitinib—pancreatic cancer	0.000445	0.0026	CcSEcCtD
Spironolactone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000445	0.00259	CcSEcCtD
Spironolactone—Body temperature increased—Irinotecan—pancreatic cancer	0.000439	0.00256	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000438	0.00256	CcSEcCtD
Spironolactone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000438	0.00255	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—pancreatic cancer	0.000431	0.00251	CcSEcCtD
Spironolactone—Vomiting—Sunitinib—pancreatic cancer	0.000428	0.0025	CcSEcCtD
Spironolactone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000427	0.00249	CcSEcCtD
Spironolactone—Rash—Sunitinib—pancreatic cancer	0.000425	0.00247	CcSEcCtD
Spironolactone—Dermatitis—Sunitinib—pancreatic cancer	0.000424	0.00247	CcSEcCtD
Spironolactone—Urticaria—Fluorouracil—pancreatic cancer	0.000422	0.00246	CcSEcCtD
Spironolactone—Headache—Sunitinib—pancreatic cancer	0.000422	0.00246	CcSEcCtD
Spironolactone—Leukopenia—Docetaxel—pancreatic cancer	0.000421	0.00245	CcSEcCtD
Spironolactone—Body temperature increased—Fluorouracil—pancreatic cancer	0.00042	0.00245	CcSEcCtD
Spironolactone—Eosinophilia—Doxorubicin—pancreatic cancer	0.000417	0.00243	CcSEcCtD
Spironolactone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000409	0.00238	CcSEcCtD
Spironolactone—Drowsiness—Epirubicin—pancreatic cancer	0.000406	0.00236	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000402	0.00234	CcSEcCtD
Spironolactone—Nausea—Sunitinib—pancreatic cancer	0.0004	0.00233	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—pancreatic cancer	0.000399	0.00232	CcSEcCtD
Spironolactone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000391	0.00228	CcSEcCtD
Spironolactone—NR3C1—digestive system—pancreatic cancer	0.000391	0.0229	CbGeAlD
Spironolactone—Confusional state—Docetaxel—pancreatic cancer	0.000387	0.00225	CcSEcCtD
Spironolactone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000383	0.00223	CcSEcCtD
Spironolactone—Pruritus—Gemcitabine—pancreatic cancer	0.000382	0.00223	CcSEcCtD
Spironolactone—Diarrhoea—Irinotecan—pancreatic cancer	0.00038	0.00221	CcSEcCtD
Spironolactone—Agranulocytosis—Epirubicin—pancreatic cancer	0.000378	0.00221	CcSEcCtD
Spironolactone—Pruritus—Fluorouracil—pancreatic cancer	0.000376	0.00219	CcSEcCtD
Spironolactone—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000375	0.00219	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—pancreatic cancer	0.000375	0.00219	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000372	0.00217	CcSEcCtD
Spironolactone—Diarrhoea—Gemcitabine—pancreatic cancer	0.00037	0.00215	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—pancreatic cancer	0.000369	0.00215	CcSEcCtD
Spironolactone—Dizziness—Irinotecan—pancreatic cancer	0.000367	0.00214	CcSEcCtD
Spironolactone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000364	0.00212	CcSEcCtD
Spironolactone—Vomiting—Irinotecan—pancreatic cancer	0.000353	0.00206	CcSEcCtD
Spironolactone—Dizziness—Fluorouracil—pancreatic cancer	0.000351	0.00205	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00035	0.00204	CcSEcCtD
Spironolactone—Rash—Irinotecan—pancreatic cancer	0.00035	0.00204	CcSEcCtD
Spironolactone—Dermatitis—Irinotecan—pancreatic cancer	0.000349	0.00204	CcSEcCtD
Spironolactone—ABCB1—islet of Langerhans—pancreatic cancer	0.000349	0.0205	CbGeAlD
Spironolactone—Headache—Irinotecan—pancreatic cancer	0.000348	0.00203	CcSEcCtD
Spironolactone—Erythema multiforme—Epirubicin—pancreatic cancer	0.000344	0.00201	CcSEcCtD
Spironolactone—Vomiting—Gemcitabine—pancreatic cancer	0.000344	0.002	CcSEcCtD
Spironolactone—Somnolence—Docetaxel—pancreatic cancer	0.000341	0.00199	CcSEcCtD
Spironolactone—Rash—Gemcitabine—pancreatic cancer	0.000341	0.00199	CcSEcCtD
Spironolactone—Dermatitis—Gemcitabine—pancreatic cancer	0.00034	0.00198	CcSEcCtD
Spironolactone—Headache—Gemcitabine—pancreatic cancer	0.000339	0.00197	CcSEcCtD
Spironolactone—Vomiting—Fluorouracil—pancreatic cancer	0.000338	0.00197	CcSEcCtD
Spironolactone—Rash—Fluorouracil—pancreatic cancer	0.000335	0.00195	CcSEcCtD
Spironolactone—Dermatitis—Fluorouracil—pancreatic cancer	0.000335	0.00195	CcSEcCtD
Spironolactone—Headache—Fluorouracil—pancreatic cancer	0.000333	0.00194	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000331	0.00193	CcSEcCtD
Spironolactone—Nausea—Irinotecan—pancreatic cancer	0.000329	0.00192	CcSEcCtD
Spironolactone—Alopecia—Epirubicin—pancreatic cancer	0.000322	0.00187	CcSEcCtD
Spironolactone—Nausea—Gemcitabine—pancreatic cancer	0.000321	0.00187	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000318	0.00186	CcSEcCtD
Spironolactone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000316	0.00184	CcSEcCtD
Spironolactone—Nausea—Fluorouracil—pancreatic cancer	0.000316	0.00184	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—pancreatic cancer	0.000305	0.00178	CcSEcCtD
Spironolactone—Body temperature increased—Docetaxel—pancreatic cancer	0.000303	0.00177	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—pancreatic cancer	0.000298	0.00173	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000294	0.00171	CcSEcCtD
Spironolactone—Malaise—Epirubicin—pancreatic cancer	0.000286	0.00167	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—pancreatic cancer	0.000284	0.00165	CcSEcCtD
Spironolactone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000283	0.00165	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—pancreatic cancer	0.000282	0.00164	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000272	0.00159	CcSEcCtD
Spironolactone—Pruritus—Docetaxel—pancreatic cancer	0.000271	0.00158	CcSEcCtD
Spironolactone—Discomfort—Epirubicin—pancreatic cancer	0.000267	0.00155	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—pancreatic cancer	0.000264	0.00154	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—pancreatic cancer	0.000262	0.00153	CcSEcCtD
Spironolactone—Diarrhoea—Docetaxel—pancreatic cancer	0.000262	0.00153	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—pancreatic cancer	0.000261	0.00152	CcSEcCtD
Spironolactone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000259	0.00151	CcSEcCtD
Spironolactone—Dizziness—Docetaxel—pancreatic cancer	0.000254	0.00148	CcSEcCtD
Spironolactone—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000253	0.00148	CcSEcCtD
Spironolactone—Discomfort—Doxorubicin—pancreatic cancer	0.000247	0.00144	CcSEcCtD
Spironolactone—ABCB1—pancreas—pancreatic cancer	0.000245	0.0144	CbGeAlD
Spironolactone—Vomiting—Docetaxel—pancreatic cancer	0.000244	0.00142	CcSEcCtD
Spironolactone—Rash—Docetaxel—pancreatic cancer	0.000242	0.00141	CcSEcCtD
Spironolactone—Dermatitis—Docetaxel—pancreatic cancer	0.000242	0.00141	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—pancreatic cancer	0.000241	0.00141	CcSEcCtD
Spironolactone—Headache—Docetaxel—pancreatic cancer	0.00024	0.0014	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000239	0.00139	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000234	0.00137	CcSEcCtD
Spironolactone—Somnolence—Epirubicin—pancreatic cancer	0.00023	0.00134	CcSEcCtD
Spironolactone—Nausea—Docetaxel—pancreatic cancer	0.000228	0.00133	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000223	0.0013	CcSEcCtD
Spironolactone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000213	0.00124	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—pancreatic cancer	0.000213	0.00124	CcSEcCtD
Spironolactone—ABCB1—digestive system—pancreatic cancer	0.000209	0.0123	CbGeAlD
Spironolactone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000207	0.0012	CcSEcCtD
Spironolactone—Urticaria—Epirubicin—pancreatic cancer	0.000205	0.0012	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—pancreatic cancer	0.000204	0.00119	CcSEcCtD
Spironolactone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000197	0.00115	CcSEcCtD
Spironolactone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000191	0.00111	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—pancreatic cancer	0.00019	0.00111	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—pancreatic cancer	0.000189	0.0011	CcSEcCtD
Spironolactone—Pruritus—Epirubicin—pancreatic cancer	0.000183	0.00107	CcSEcCtD
Spironolactone—Diarrhoea—Epirubicin—pancreatic cancer	0.000177	0.00103	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000176	0.00103	CcSEcCtD
Spironolactone—Dizziness—Epirubicin—pancreatic cancer	0.000171	0.000997	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—pancreatic cancer	0.000169	0.000987	CcSEcCtD
Spironolactone—Vomiting—Epirubicin—pancreatic cancer	0.000164	0.000958	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—pancreatic cancer	0.000164	0.000954	CcSEcCtD
Spironolactone—Rash—Epirubicin—pancreatic cancer	0.000163	0.00095	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—pancreatic cancer	0.000163	0.000949	CcSEcCtD
Spironolactone—Headache—Epirubicin—pancreatic cancer	0.000162	0.000944	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—pancreatic cancer	0.000158	0.000922	CcSEcCtD
Spironolactone—Nausea—Epirubicin—pancreatic cancer	0.000154	0.000895	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—pancreatic cancer	0.000152	0.000887	CcSEcCtD
Spironolactone—Rash—Doxorubicin—pancreatic cancer	0.000151	0.000879	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—pancreatic cancer	0.000151	0.000879	CcSEcCtD
Spironolactone—Headache—Doxorubicin—pancreatic cancer	0.00015	0.000874	CcSEcCtD
Spironolactone—Nausea—Doxorubicin—pancreatic cancer	0.000142	0.000828	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—AKT1—pancreatic cancer	7.25e-05	0.000739	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PPP2R5B—pancreatic cancer	7.22e-05	0.000736	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRP1—pancreatic cancer	7.22e-05	0.000736	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	7.22e-05	0.000735	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—EZH2—pancreatic cancer	7.13e-05	0.000726	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFB1—pancreatic cancer	7.12e-05	0.000725	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—pancreatic cancer	7.11e-05	0.000724	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	7.04e-05	0.000718	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	7.02e-05	0.000716	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH3—pancreatic cancer	6.98e-05	0.000711	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HEY2—pancreatic cancer	6.95e-05	0.000709	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CD44—pancreatic cancer	6.95e-05	0.000708	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	6.94e-05	0.000707	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	6.88e-05	0.000701	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	6.87e-05	0.0007	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	6.84e-05	0.000697	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	6.82e-05	0.000695	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.8e-05	0.000693	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GAST—pancreatic cancer	6.79e-05	0.000692	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.74e-05	0.000687	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.72e-05	0.000685	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	6.7e-05	0.000683	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GCG—pancreatic cancer	6.66e-05	0.000679	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	6.64e-05	0.000677	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	6.62e-05	0.000675	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—HSPA1A—pancreatic cancer	6.61e-05	0.000673	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MEN1—pancreatic cancer	6.59e-05	0.000672	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	6.58e-05	0.000671	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	6.49e-05	0.000662	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMP—pancreatic cancer	6.44e-05	0.000656	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SCT—pancreatic cancer	6.44e-05	0.000656	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HEY1—pancreatic cancer	6.44e-05	0.000656	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	6.44e-05	0.000656	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—pancreatic cancer	6.38e-05	0.00065	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NOTCH1—pancreatic cancer	6.36e-05	0.000648	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	6.31e-05	0.000643	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—STK11—pancreatic cancer	6.26e-05	0.000638	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH4—pancreatic cancer	6.25e-05	0.000637	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	6.18e-05	0.00063	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCK—pancreatic cancer	6.14e-05	0.000626	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	6.13e-05	0.000625	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	6.13e-05	0.000625	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PPARG—pancreatic cancer	6e-05	0.000612	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CD44—pancreatic cancer	5.99e-05	0.00061	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CNR2—pancreatic cancer	5.98e-05	0.00061	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GLP1R—pancreatic cancer	5.98e-05	0.00061	CbGpPWpGaD
Spironolactone—AR—Gene Expression—HSPA1B—pancreatic cancer	5.96e-05	0.000608	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	5.96e-05	0.000607	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCKAR—pancreatic cancer	5.89e-05	0.0006	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.88e-05	0.000599	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.86e-05	0.000597	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.81e-05	0.000592	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	5.78e-05	0.00059	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GCG—pancreatic cancer	5.74e-05	0.000585	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JAG2—pancreatic cancer	5.71e-05	0.000582	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	5.64e-05	0.000574	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MEN1—pancreatic cancer	5.63e-05	0.000573	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	5.56e-05	0.000566	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	5.52e-05	0.000562	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	5.47e-05	0.000557	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.45e-05	0.000556	CbGpPWpGaD
Spironolactone—AR—Gene Expression—EZH2—pancreatic cancer	5.43e-05	0.000553	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—STK11—pancreatic cancer	5.4e-05	0.00055	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TYMS—pancreatic cancer	5.39e-05	0.000549	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SHH—pancreatic cancer	5.37e-05	0.000547	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH4—pancreatic cancer	5.33e-05	0.000544	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.31e-05	0.000542	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH3—pancreatic cancer	5.31e-05	0.000542	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IAPP—pancreatic cancer	5.3e-05	0.00054	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SMAD4—pancreatic cancer	5.25e-05	0.000535	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GLP1R—pancreatic cancer	5.19e-05	0.000529	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—DPYD—pancreatic cancer	5.11e-05	0.000521	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—pancreatic cancer	5.11e-05	0.000521	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTHLH—pancreatic cancer	5.09e-05	0.000519	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTCH1—pancreatic cancer	5.09e-05	0.000519	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	5.08e-05	0.000517	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.06e-05	0.000516	CbGpPWpGaD
Spironolactone—AR—Gene Expression—HSPA1A—pancreatic cancer	5.03e-05	0.000513	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MEN1—pancreatic cancer	5e-05	0.00051	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.86e-05	0.000495	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SLC2A2—pancreatic cancer	4.85e-05	0.000494	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.8e-05	0.000489	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	4.74e-05	0.000483	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SST—pancreatic cancer	4.65e-05	0.000474	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	4.65e-05	0.000474	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TYMS—pancreatic cancer	4.64e-05	0.000473	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.63e-05	0.000472	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.6e-05	0.000469	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JAG1—pancreatic cancer	4.55e-05	0.000464	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH3—pancreatic cancer	4.54e-05	0.000462	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	4.52e-05	0.000461	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.43e-05	0.000451	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	4.39e-05	0.000447	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	4.39e-05	0.000447	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—APOE—pancreatic cancer	4.38e-05	0.000446	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—pancreatic cancer	4.33e-05	0.000441	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CNR1—pancreatic cancer	4.3e-05	0.000438	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.22e-05	0.00043	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PRSS1—pancreatic cancer	4.18e-05	0.000426	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GCG—pancreatic cancer	4.15e-05	0.000423	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.15e-05	0.000423	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—EZH2—pancreatic cancer	4.12e-05	0.00042	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	4.03e-05	0.000411	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SMAD4—pancreatic cancer	4e-05	0.000408	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AGTR1—pancreatic cancer	3.96e-05	0.000403	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CG—pancreatic cancer	3.95e-05	0.000403	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STK11—pancreatic cancer	3.9e-05	0.000397	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH1—pancreatic cancer	3.87e-05	0.000395	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	3.82e-05	0.000389	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARG—pancreatic cancer	3.82e-05	0.000389	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—APOE—pancreatic cancer	3.77e-05	0.000385	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CD44—pancreatic cancer	3.75e-05	0.000383	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.73e-05	0.00038	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.68e-05	0.000375	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARG—pancreatic cancer	3.66e-05	0.000373	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.64e-05	0.000371	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PRSS1—pancreatic cancer	3.64e-05	0.000371	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ARG2—pancreatic cancer	3.62e-05	0.000369	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GCG—pancreatic cancer	3.6e-05	0.000367	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.57e-05	0.000364	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CD—pancreatic cancer	3.48e-05	0.000354	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.47e-05	0.000353	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—pancreatic cancer	3.42e-05	0.000349	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SMAD4—pancreatic cancer	3.42e-05	0.000348	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CG—pancreatic cancer	3.41e-05	0.000347	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—STK11—pancreatic cancer	3.38e-05	0.000345	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.37e-05	0.000344	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.34e-05	0.00034	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HES1—pancreatic cancer	3.34e-05	0.00034	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—pancreatic cancer	3.3e-05	0.000336	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—pancreatic cancer	3.29e-05	0.000335	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.26e-05	0.000332	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.18e-05	0.000324	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMP—pancreatic cancer	3.16e-05	0.000323	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ARG2—pancreatic cancer	3.15e-05	0.000321	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SMAD4—pancreatic cancer	3.04e-05	0.00031	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CB—pancreatic cancer	3.03e-05	0.000309	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.02e-05	0.000308	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—pancreatic cancer	3e-05	0.000306	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CD—pancreatic cancer	2.99e-05	0.000305	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH1—pancreatic cancer	2.95e-05	0.000301	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.94e-05	0.0003	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—pancreatic cancer	2.92e-05	0.000298	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMS—pancreatic cancer	2.91e-05	0.000297	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HIF1A—pancreatic cancer	2.8e-05	0.000285	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TSC2—pancreatic cancer	2.79e-05	0.000284	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—pancreatic cancer	2.78e-05	0.000284	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMP—pancreatic cancer	2.76e-05	0.000281	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOE—pancreatic cancer	2.73e-05	0.000278	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.71e-05	0.000276	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.7e-05	0.000275	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KDR—pancreatic cancer	2.67e-05	0.000272	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.65e-05	0.00027	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—pancreatic cancer	2.62e-05	0.000267	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.61e-05	0.000266	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CB—pancreatic cancer	2.61e-05	0.000266	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—pancreatic cancer	2.59e-05	0.000264	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GLP1R—pancreatic cancer	2.55e-05	0.00026	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NFKBIA—pancreatic cancer	2.54e-05	0.000259	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.52e-05	0.000257	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH1—pancreatic cancer	2.52e-05	0.000257	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—DPYD—pancreatic cancer	2.51e-05	0.000256	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	2.5e-05	0.000255	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.5e-05	0.000255	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—pancreatic cancer	2.46e-05	0.000251	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGF—pancreatic cancer	2.43e-05	0.000248	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	2.38e-05	0.000243	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—pancreatic cancer	2.37e-05	0.000242	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOE—pancreatic cancer	2.37e-05	0.000241	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.36e-05	0.00024	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.3e-05	0.000234	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.27e-05	0.000232	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—pancreatic cancer	2.26e-05	0.00023	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.24e-05	0.000228	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	2.24e-05	0.000228	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.22e-05	0.000227	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.22e-05	0.000226	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—DPYD—pancreatic cancer	2.19e-05	0.000223	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CD—pancreatic cancer	2.16e-05	0.000221	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	2.14e-05	0.000218	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—pancreatic cancer	2.11e-05	0.000215	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—pancreatic cancer	2.08e-05	0.000212	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A2—pancreatic cancer	2.07e-05	0.000211	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.07e-05	0.000211	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—pancreatic cancer	2.06e-05	0.00021	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CB—pancreatic cancer	1.89e-05	0.000192	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	1.88e-05	0.000191	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.88e-05	0.000191	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—pancreatic cancer	1.85e-05	0.000188	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CD44—pancreatic cancer	1.84e-05	0.000188	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—pancreatic cancer	1.81e-05	0.000185	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.81e-05	0.000184	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.79e-05	0.000182	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GCG—pancreatic cancer	1.77e-05	0.00018	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—pancreatic cancer	1.74e-05	0.000177	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—pancreatic cancer	1.69e-05	0.000172	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—pancreatic cancer	1.67e-05	0.00017	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—STK11—pancreatic cancer	1.66e-05	0.000169	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—pancreatic cancer	1.64e-05	0.000167	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	1.64e-05	0.000167	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—pancreatic cancer	1.63e-05	0.000166	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	1.62e-05	0.000165	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CD44—pancreatic cancer	1.61e-05	0.000164	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—pancreatic cancer	1.59e-05	0.000162	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—pancreatic cancer	1.59e-05	0.000162	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.56e-05	0.000159	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GCG—pancreatic cancer	1.54e-05	0.000157	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SRC—pancreatic cancer	1.51e-05	0.000154	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—pancreatic cancer	1.51e-05	0.000154	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—pancreatic cancer	1.47e-05	0.00015	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—pancreatic cancer	1.46e-05	0.000149	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—pancreatic cancer	1.45e-05	0.000148	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—STK11—pancreatic cancer	1.45e-05	0.000148	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—pancreatic cancer	1.45e-05	0.000147	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.43e-05	0.000146	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—pancreatic cancer	1.41e-05	0.000144	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—pancreatic cancer	1.35e-05	0.000138	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—pancreatic cancer	1.35e-05	0.000138	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—pancreatic cancer	1.33e-05	0.000135	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—pancreatic cancer	1.3e-05	0.000132	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—pancreatic cancer	1.25e-05	0.000128	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMS—pancreatic cancer	1.25e-05	0.000127	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—pancreatic cancer	1.2e-05	0.000123	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOE—pancreatic cancer	1.16e-05	0.000119	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	1.15e-05	0.000117	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—pancreatic cancer	1.11e-05	0.000113	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—pancreatic cancer	1.1e-05	0.000112	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.1e-05	0.000112	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—pancreatic cancer	1.06e-05	0.000108	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	1.05e-05	0.000107	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOE—pancreatic cancer	1.01e-05	0.000103	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—pancreatic cancer	1.01e-05	0.000103	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	9.98e-06	0.000102	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—pancreatic cancer	9.4e-06	9.58e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	9.23e-06	9.4e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	9.14e-06	9.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—pancreatic cancer	8.83e-06	8.99e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—pancreatic cancer	8.35e-06	8.51e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—pancreatic cancer	8.15e-06	8.31e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	8.04e-06	8.2e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	8.04e-06	8.19e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—pancreatic cancer	7.97e-06	8.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	7.01e-06	7.14e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—pancreatic cancer	6.95e-06	7.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—pancreatic cancer	6.94e-06	7.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—pancreatic cancer	6.05e-06	6.17e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	4.9e-06	5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	4.27e-06	4.35e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—pancreatic cancer	4.01e-06	4.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—pancreatic cancer	3.49e-06	3.56e-05	CbGpPWpGaD
